Allakos Announces Presentation from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting

NEXT STORY
Novavax Announces Facility Expansion to Support Global Vaccine Development
PREV STORY
Kaleido Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Basilea gibt Clinical Supply Agreement für geplante FIDES-03-Studie mit Derazantinib bei Magenkrebs bekannt

author_avatar
NASDAQ Market News

Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements 

-- Initiated Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis ---- ...

author_avatar
NASDAQ Market News

OpGen Highlights Acuitas® Analytical Validation Data for Rapidly Predicting Antibiotic Resistance Using Drug Resistance Gene Profiles at ECCMID

author_avatar
NASDAQ Market News